Growing community of inventors

Maidenhead, United Kingdom

David Festus Charles Moffat

Average Co-Inventor Count = 3.07

ph-index = 6

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 532

David Festus Charles MoffatPeter David Davis (5 patents)David Festus Charles MoffatMartin Clive Hutchings (4 patents)David Festus Charles MoffatJeremy Martin Davis (4 patents)David Festus Charles MoffatMark James Batchelor (3 patents)David Festus Charles MoffatDavid Mark Parry (1 patent)David Festus Charles MoffatDavid Festus Charles Moffat (7 patents)Peter David DavisPeter David Davis (20 patents)Martin Clive HutchingsMartin Clive Hutchings (21 patents)Jeremy Martin DavisJeremy Martin Davis (19 patents)Mark James BatchelorMark James Batchelor (14 patents)David Mark ParryDavid Mark Parry (2 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Celltech R&d Limited (5 from 68 patents)

2. Celltech Therapeutics Limited (2 from 81 patents)


7 patents:

1. 7012076 - Bicyclic amine derivatives as inhibitors of class 1 receptor tyrosine kinases

2. 6600037 - 4,5-disubstituted-2-aminopyrimidines

3. 6599908 - Fused polycyclic 2-aminopyrimidine derivatives

4. 6579983 - 5-cyano-2-aminopyrimidine derivatives

5. 6552029 - 2-pyrimidineamine derivatives and processes for their preparation

6. 6337335 - Substituted 2-anilinopyrimidines useful as protein kinase inhibitors

7. 6235746 - Substituted 2-anilinopyrimidines useful as protein kinase inhibitors

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/5/2025
Loading…